# Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B

> **NCT03120494** · PHASE4 · UNKNOWN · sponsor: **Puerto Rico Community Network for Clinical Research on AIDS** · enrollment: 75 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Emtricitabine and Tenofovir

## Key facts

- **NCT ID:** NCT03120494
- **Lead sponsor:** Puerto Rico Community Network for Clinical Research on AIDS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2019-06
- **Final completion:** 2019-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120494, "Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03120494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*